PeptiDream reports former executive misappropriated 54m yen in reagents

PeptiDream's investigation found a former vice president and chief operating officer misappropriated reagents worth 54.3 million yen between March 2017 and January 2025.

The executive also received 59.3 million yen from three business partners for unauthorized consulting services. The company said the financial impact was minor.